Future opportunity

In vitro skin penetration studies (LSRS026)

  • Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

F01: Prior information notice (prior information only)

Notice reference: 2022/S 000-030772

Published 1 November 2022, 10:04am



Section one: Contracting authority

one.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Nobel House, 17 Smith Square

London

SW1P 3JR

Contact

Susan Duncan-Wood

Email

susan.duncanwood@ukhsa.gov.uk

Country

United Kingdom

NUTS code

UKI32 - Westminster

Internet address(es)

Main address

https://www.gov.uk/government/organisations/uk-health-security-agency

Buyer's address

https://www.gov.uk/government/organisations/uk-health-security-agency

one.3) Communication

Additional information can be obtained from the above-mentioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

https://health-family.force.com/s/Welcome

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

In vitro skin penetration studies (LSRS026)

two.1.2) Main CPV code

  • 73110000 - Research services

two.1.3) Type of contract

Services

two.1.4) Short description

The UK Health Security Agency (UKHSA) wishes to inform the market of a potential future procurement to source a suitably qualified supplier deliver a series of two linked in vitro experiments, using a skin diffusion cell system:

two.1.5) Estimated total value

Value excluding VAT: £225,250

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKI32 - Westminster

two.2.4) Description of the procurement

In vitro skin penetration studies to identify optimal decontamination parameters for chemical simulants and toxic powders


The UK Health Security Agency (UKHSA) wishes to inform the market of a potential future procurement to source a suitably qualified supplier deliver a series of two linked in vitro experiments, using a skin diffusion cell system:

The presently anticipated route to the market will be under the auspices of a Regulation 14 (Research) exemption of the Public Contracts Regulations 2015 (as amended) however the Authority wishes to proceed with a fair and transparent competition

Therefore, Requests for Proposal (RFP) will be issued to all those Expressing an Interest (EOI) as a result of this market engagement; and any bids received will be evaluated in accordance with Most Economically Advantageous Tender (MEAT) principles using the project specific evaluation criteria detailed in the RFP.

two.3) Estimated date of publication of contract notice

1 November 2022


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No